Grifols

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!

About GRFS

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. 

CEO
Jose Ignacio Abia Buenache
CEOJose Ignacio Abia Buenache
Employees
25,258
Employees25,258
Headquarters
Barcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded
1909
Founded1909
Employees
25,258
Employees25,258

GRFS Key Statistics

Market cap
6.52B
Market cap6.52B
Price-Earnings ratio
12.03
Price-Earnings ratio12.03
Dividend yield
1.78%
Dividend yield1.78%
Average volume
782.46K
Average volume782.46K
High today
$7.96
High today$7.96
Low today
$7.76
Low today$7.76
Open price
$7.92
Open price$7.92
Volume
472.07K
Volume472.07K
52 Week high
$11.14
52 Week high$11.14
52 Week low
$6.19
52 Week low$6.19

GRFS News

TipRanks 1d
Grifols shares results of Chronos Platforms identifying early Parkinson’s

Grifols (GRFS) shared proof-of-concept data from its Chronos-PD program, demonstrating that biological changes in individuals with Parkinson’s disease occur mor...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.